Any ether carrying a hydroxy group at unspecified position.
ChEBI ID: 46789
Member | Definition | Role |
---|---|---|
5-benzylacyclouridine | A pyrimidone that is uracil which is substituted by a 2-hydroxyethoxymethyl group at position 1 and a benzyl group at position 5. | 5-benzyl-1-(2-hydroxyethoxymethyl)uracil |
5-benzyloxybenzylacyclouridine | A benzyl ether that consists of acyclouridine bearing a 3-(benzyloxy)benzyl substituent at position 5. | 5-benzyloxybenzylacyclouridine |
aethoxysclerol | A hydroxyether that is ethylene glycol substituted on one of the oxygens by a dodecyl group. | ethylene glycol monododecyl ether |
diethylene glycol | diethylene glycol | |
hydroxyzine | A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively. | hydroxyzine |
ticagrelor | A triazolopyrimidine that is an adenosine isostere; the cyclopentane ring is similar to ribose and the nitrogen-rich [1,2,3]triazolo[4,5-d]pyrimidine moiety resembles the nucleobase adenine. A platelet aggregation inhibitor which is used for prevention of thromboembolic events in patients with acute coronary syndrome. | ticagrelor |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 792 (20.05) | 18.7374 |
1990's | 245 (6.20) | 18.2507 |
2000's | 267 (6.76) | 29.6817 |
2010's | 1,686 (42.67) | 24.3611 |
2020's | 961 (24.32) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 945 (22.20%) | 5.53% |
Reviews | 542 (12.73%) | 6.00% |
Case Studies | 315 (7.40%) | 4.05% |
Observational | 128 (3.01%) | 0.25% |
Other | 2,327 (54.66%) | 84.16% |